PCK1 and liver cancer: Overexpression of PCK1 can reduce the survival rate of liver cancer cell lines, induce apoptosis, inhibit cell migration, and activate the expression of PCK1 and thus may be potentially utilized as a therapeutic strategy for liver cancer (Liu MX.